Tag(s):
Grifols/Talecris gets FTC green light
Thursday, 02 June 2011
The US Federal Trade Commission (FTC) has approved the buyout of pharmaceutical company Talecris by rival Grifols, subject to divestitures.
CSL and Baxter hit with twin antitrust suits
Premium Article - Monday, 24 August 2009
US health-care provider Solaris Health Systems has filed a proposed antitrust class action alleging biotherapeutics companies CSL and Baxter International conspired to fix the price of life-saving blood plasma treatments.



